Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Антифосфолипидный синдром у пациента, перенесшего сифилитическую инфекцию
Антифосфолипидный синдром у пациента, перенесшего сифилитическую инфекцию
Жучков М.В., Большакова Е.Е., Сонин Д.Б. и др. Антифосфолипидный синдром у пациента, перенесшего сифилитическую инфекцию. Consilium Medicum. 2019; 21 (12.2): 31–33. DOI: 10.26442/24143537.2019.1.190204
DOI: 10.26442/24143537.2019.1.190204
________________________________________________
DOI: 10.26442/24143537.2019.1.190204
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
В статье приводятся обзорные данные и клиническое наблюдение случая антифосфолипидного синдрома у пациента, перенесшего сифилитическую инфекцию. Обсуждаются сложности диагностики антифосфолипидного синдрома у пациентов с феноменом серологической резистентности и возможности патогенетической связи Treponema pallidum-ассоциированной инфекции и выработки антифосфолипидных антител.
Ключевые слова: антифосфолипидный синдром, сифилис, серологическая резистентность.
Key words: antiphospholipid syndrome, syphilis, seroresistanсe.
Ключевые слова: антифосфолипидный синдром, сифилис, серологическая резистентность.
________________________________________________
Key words: antiphospholipid syndrome, syphilis, seroresistanсe.
Полный текст
Список литературы
1. Wassermann A, Neisser A, Bruck C. Ein serodiagnostische Reaktion bei Syphilis. Deutsche Med Wochenschr 1906; 32: 745–6.
2. Pangborn MC. Isolation and purification of a serologically active phospholipid from beef heart. О Biol Chem 1942; 143: 247.
3. Moor JE, Mohr CF. Biologycally false positive serological test for syphilis. Type, incidence, and cause. J Am Med Assoc 1952; 150: 467–73.
4. Conley CL, Hartmann RC. Haemorrhagic disorder caused by ciculating anticoagulant in patient with disseminated lupus erythematosus. J Clin Invest 1952; 31: 621–2.
5. Bowie EJW, Thompson JH, Pascuzzi CA, Owen CA. Trombosis in systemic lupus erythematosus despite circulating anticoagulant. Arthritis Rheum 1963; 62: 416–30.
6. Harris EN et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211–4.
7. Hughes GRV. Connective tissue disease and the skin. The Prosser White Oration 1983. Clin Exp Dermatol 1984; 9: 535–44.
8. Кубанова А.А., Мелехина Л.Е., Кубанов А.А., Богданова Е.Б. Заболеваемость сифилисом в Российской Федерации за период 2004–2013 гг. Вестн. дерматологии и венерологии. 2014; 5: 24–31. / Kubanova A.A., Melekhina L.E., Kubanov A.A., Bogdanova E.B. Zabolevaemost' sifilisom v Rossiiskoi Federatsii za period 2004–2013 gg. Vestn. dermatologii i venerologii. 2014; 5: 24–31. [in Russian]
9. Дмитриев Г.А., Афонин А.В. О возможной причине возникновения серорезистентности при сифилитической инфекции. Вестн. дерматологии и венерологии. 2003; 2: 26–9. / Dmitriev G.A., Afonin A.V. O vozmozhnoi prichine vozniknoveniia serorezistentnosti pri sifiliticheskoi infektsii. Vestn. dermatologii i venerologii. 2003; 2: 26–9. [in Russian]
10. Loizou S et al. Similarities of specificity and cofactor dependency in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 103–8.
11. Gotoh M, Matsuda J. Induction of anticardiolipin antibody and/or lupus anticoagulant in rabbit by immunization with lipoteichoic acid, lipipolysaccharide and lipid. Lupus 1996; 5: 593–7.
12. Gharavi A et al. Antiphospholipid antibody inducted in mice by immunization with a cytomegalovirus – derived peptide cause thrombosis and activation of endothelial cells in vitro. Arthritis Rheum 2002; 46: 545–52.
2. Pangborn MC. Isolation and purification of a serologically active phospholipid from beef heart. О Biol Chem 1942; 143: 247.
3. Moor JE, Mohr CF. Biologycally false positive serological test for syphilis. Type, incidence, and cause. J Am Med Assoc 1952; 150: 467–73.
4. Conley CL, Hartmann RC. Haemorrhagic disorder caused by ciculating anticoagulant in patient with disseminated lupus erythematosus. J Clin Invest 1952; 31: 621–2.
5. Bowie EJW, Thompson JH, Pascuzzi CA, Owen CA. Trombosis in systemic lupus erythematosus despite circulating anticoagulant. Arthritis Rheum 1963; 62: 416–30.
6. Harris EN et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211–4.
7. Hughes GRV. Connective tissue disease and the skin. The Prosser White Oration 1983. Clin Exp Dermatol 1984; 9: 535–44.
8. Kubanova A.A., Melekhina L.E., Kubanov A.A., Bogdanova E.B. Zabolevaemost' sifilisom v Rossiiskoi Federatsii za period 2004–2013 gg. Vestn. dermatologii i venerologii. 2014; 5: 24–31. [in Russian]
9. Dmitriev G.A., Afonin A.V. O vozmozhnoi prichine vozniknoveniia serorezistentnosti pri sifiliticheskoi infektsii. Vestn. dermatologii i venerologii. 2003; 2: 26–9. [in Russian]
10. Loizou S et al. Similarities of specificity and cofactor dependency in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 103–8.
11. Gotoh M, Matsuda J. Induction of anticardiolipin antibody and/or lupus anticoagulant in rabbit by immunization with lipoteichoic acid, lipipolysaccharide and lipid. Lupus 1996; 5: 593–7.
12. Gharavi A et al. Antiphospholipid antibody inducted in mice by immunization with a cytomegalovirus – derived peptide cause thrombosis and activation of endothelial cells in vitro. Arthritis Rheum 2002; 46: 545–52.
2. Pangborn MC. Isolation and purification of a serologically active phospholipid from beef heart. О Biol Chem 1942; 143: 247.
3. Moor JE, Mohr CF. Biologycally false positive serological test for syphilis. Type, incidence, and cause. J Am Med Assoc 1952; 150: 467–73.
4. Conley CL, Hartmann RC. Haemorrhagic disorder caused by ciculating anticoagulant in patient with disseminated lupus erythematosus. J Clin Invest 1952; 31: 621–2.
5. Bowie EJW, Thompson JH, Pascuzzi CA, Owen CA. Trombosis in systemic lupus erythematosus despite circulating anticoagulant. Arthritis Rheum 1963; 62: 416–30.
6. Harris EN et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211–4.
7. Hughes GRV. Connective tissue disease and the skin. The Prosser White Oration 1983. Clin Exp Dermatol 1984; 9: 535–44.
8. Кубанова А.А., Мелехина Л.Е., Кубанов А.А., Богданова Е.Б. Заболеваемость сифилисом в Российской Федерации за период 2004–2013 гг. Вестн. дерматологии и венерологии. 2014; 5: 24–31. / Kubanova A.A., Melekhina L.E., Kubanov A.A., Bogdanova E.B. Zabolevaemost' sifilisom v Rossiiskoi Federatsii za period 2004–2013 gg. Vestn. dermatologii i venerologii. 2014; 5: 24–31. [in Russian]
9. Дмитриев Г.А., Афонин А.В. О возможной причине возникновения серорезистентности при сифилитической инфекции. Вестн. дерматологии и венерологии. 2003; 2: 26–9. / Dmitriev G.A., Afonin A.V. O vozmozhnoi prichine vozniknoveniia serorezistentnosti pri sifiliticheskoi infektsii. Vestn. dermatologii i venerologii. 2003; 2: 26–9. [in Russian]
10. Loizou S et al. Similarities of specificity and cofactor dependency in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 103–8.
11. Gotoh M, Matsuda J. Induction of anticardiolipin antibody and/or lupus anticoagulant in rabbit by immunization with lipoteichoic acid, lipipolysaccharide and lipid. Lupus 1996; 5: 593–7.
12. Gharavi A et al. Antiphospholipid antibody inducted in mice by immunization with a cytomegalovirus – derived peptide cause thrombosis and activation of endothelial cells in vitro. Arthritis Rheum 2002; 46: 545–52.
________________________________________________
2. Pangborn MC. Isolation and purification of a serologically active phospholipid from beef heart. О Biol Chem 1942; 143: 247.
3. Moor JE, Mohr CF. Biologycally false positive serological test for syphilis. Type, incidence, and cause. J Am Med Assoc 1952; 150: 467–73.
4. Conley CL, Hartmann RC. Haemorrhagic disorder caused by ciculating anticoagulant in patient with disseminated lupus erythematosus. J Clin Invest 1952; 31: 621–2.
5. Bowie EJW, Thompson JH, Pascuzzi CA, Owen CA. Trombosis in systemic lupus erythematosus despite circulating anticoagulant. Arthritis Rheum 1963; 62: 416–30.
6. Harris EN et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211–4.
7. Hughes GRV. Connective tissue disease and the skin. The Prosser White Oration 1983. Clin Exp Dermatol 1984; 9: 535–44.
8. Kubanova A.A., Melekhina L.E., Kubanov A.A., Bogdanova E.B. Zabolevaemost' sifilisom v Rossiiskoi Federatsii za period 2004–2013 gg. Vestn. dermatologii i venerologii. 2014; 5: 24–31. [in Russian]
9. Dmitriev G.A., Afonin A.V. O vozmozhnoi prichine vozniknoveniia serorezistentnosti pri sifiliticheskoi infektsii. Vestn. dermatologii i venerologii. 2003; 2: 26–9. [in Russian]
10. Loizou S et al. Similarities of specificity and cofactor dependency in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 103–8.
11. Gotoh M, Matsuda J. Induction of anticardiolipin antibody and/or lupus anticoagulant in rabbit by immunization with lipoteichoic acid, lipipolysaccharide and lipid. Lupus 1996; 5: 593–7.
12. Gharavi A et al. Antiphospholipid antibody inducted in mice by immunization with a cytomegalovirus – derived peptide cause thrombosis and activation of endothelial cells in vitro. Arthritis Rheum 2002; 46: 545–52.
Авторы
М.В. Жучков*1, Е.Е. Большакова1, Д.Б. Сонин1, Е.Е. Жильцова2, Р.Р. Шилин2, М.С. Исакова1, С.А. Родионова1, И.Е. Минкина1
1 ГБУ РО «Областной клинический кожно-венерологический диспансер»;
2 ФГБОУ ВО «Рязанский государственный медицинский университет им. акад. И.П. Павлова» Минздрава России
*misha.juchkov@gmail.com
1 Ryazan State Regional Dermato-Venerological Clinic;
2 I.P. Pavlov Ryazan State Medical University of the Ministry of Health of the Russian Federation
*misha.juchkov@gmail.com
1 ГБУ РО «Областной клинический кожно-венерологический диспансер»;
2 ФГБОУ ВО «Рязанский государственный медицинский университет им. акад. И.П. Павлова» Минздрава России
*misha.juchkov@gmail.com
________________________________________________
1 Ryazan State Regional Dermato-Venerological Clinic;
2 I.P. Pavlov Ryazan State Medical University of the Ministry of Health of the Russian Federation
*misha.juchkov@gmail.com
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.